These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4138380)

  • 1. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Oct; 2(7886):966-7. PubMed ID: 4138380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rauwolfia preparations and breast cancer].
    Ugeskr Laeger; 1974 Nov; 136(45):2536. PubMed ID: 4425388
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Rauwolfia derivatives and breast cancer.
    Magnus K
    Lancet; 1974 Nov; 2(7888):1080. PubMed ID: 4138381
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Rauwolfia derivatives and breast cancer.
    Med J Aust; 1974 Nov; 2(20):722. PubMed ID: 4444628
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative evaluation of Rauwolfia whole root and reserpine.
    Smith WM; Thurm RH; Bromer L
    Clin Pharmacol Ther; 1969; 10(3):338-43. PubMed ID: 5795801
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Rauwolfia and breast cancer.
    Br Med J; 1974 Oct; 4(5937):121-2. PubMed ID: 4423116
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Nov; 2(7892):1315-7. PubMed ID: 4139545
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of hypertension.
    Grenfell RF
    South Med J; 1971 Nov; 64(11):1358-61. PubMed ID: 5126799
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Rauwolfia derivatives and breast cancer.
    Jus A; Pineau R; Hazzi N
    Am J Psychiatry; 1976 Apr; 133(4):451-2. PubMed ID: 1267050
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland.
    Aromaa A; Hakama M; Hakulinen T; Saxén E; Teppo L; Idä lan-Heikkilä J
    Int J Cancer; 1976 Dec; 18(6):727-38. PubMed ID: 992904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Oct; 2(7884):833. PubMed ID: 4138379
    [No Abstract]   [Full Text] [Related]  

  • 12. Reserpine and breast cancer in a retirement community.
    Mack TM; Henderson BE; Gerkins VR; Arthur M; Baptista J; Pike MC
    N Engl J Med; 1975 Jun; 292(26):1366-71. PubMed ID: 1138164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.
    Armstrong B; Stevens N; Doll R
    Lancet; 1974 Sep; 2(7882):672-5. PubMed ID: 4142956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the clinico-metabolic effects of administration of an association of rauwolfia, vasoactive drugs and hydroflumethiazide in a group of hypertensive patients].
    Pupita F; Piccioli R
    Policlinico Med; 1971; 78(5):229-37. PubMed ID: 4399831
    [No Abstract]   [Full Text] [Related]  

  • 15. Rauwolfia derivatives and breast cancer.
    Christopher LJ; Crooks J; Moir D; Weir RD
    Lancet; 1977 Jan; 1(8003):140-1. PubMed ID: 64670
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory observations on the use of a combination of methyclothiazide and deserpidine in treatment of essential hypertension.
    Shafei AZ; Abaza HH
    J Egypt Med Assoc; 1968; 51(1):48-56. PubMed ID: 4876817
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Rauwolfia derivatives and cancer.
    Bock KD; Cottier PT; Freis ED; Gross F; Peart WS; Robertson JI
    Lancet; 1974 Oct; 2(7885):895. PubMed ID: 4137803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methylclothizide-deseppidine combination in the management of patients with essential arterial hypertension].
    Andretto IE
    Hospital (Rio J); 1968 Jun; 73(6):1899-906. PubMed ID: 5305594
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of arterial hypertension through the synergism of a central hypotensor (rescinnamine) and a vasotropic drug (trimetazidine)].
    Santana ET; Seixas A; Tashima F; Toshio OM; Santana MA; de Freitas Z
    Hospital (Rio J); 1968 Nov; 74(5):1701-6. PubMed ID: 4388712
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical laboratory study of essential hypertension patients treated with a methylclothiazide deserpidine combination].
    da Rocha AL; Saldanha RV
    Hospital (Rio J); 1968 Oct; 74(4):1299-304. PubMed ID: 5304160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.